C2N Diagnostics, a world leader in advanced brain health diagnostics, has reached an exceptional new milestone with the submission of its innovative, accessible blood test to the U.S. Food and Drug ...

Regulated utility stocks show reliable dividend growth. Explore AEP, NextEra, and H2O America's strengths and income ...

Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...

Current AI debates regarding booming vendor revenue and high failure rates miss the real question of: Who is actually getting value from AI? In this guest commentary, Ganesh Padmanabhan of Autonomize ...

Emily Scherer has been teaching fifth-grade English in Newport, Vermont, for nearly a decade. In this remote, poor corner of ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

Understanding the neural mechanisms underlying associative threat learning is essential for advancing behavioral models of threat and adaptation. We investigated distinct activation patterns across ...

The quarter closed not with expected rebalancing drama but with a slow exhale, markets drifting higher as though walking a tightrope strung across late-summer skies. The S&P 500 ended September with ...

The three major indices in the United States fell early on Wednesday, only to bounce a bit and show signs of life. At this point in time, the markets are still very bullish overall.

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

Gold (XAU/USD) soars to yet another record high on Wednesday, extending its relentless climb as the United States (US) government shutdown fuels safe-haven demand. At the time of writing, XAU/USD is ...

Join us for a blow-by-blow account of the debate between incumbent Democratic Mayor Justin Elicker and Republican challenger ...